16 results
424B5
COGT
Cogent Biosciences Inc
2 Dec 20
Prospectus supplement for primary offering
5:06pm
the pressure on drug pricing. Coverage policies, third-party reimbursement rates and drug pricing regulation may change at any time. In particular
424B5
a3aay5
30 Nov 20
Prospectus supplement for primary offering
5:28pm
DEFM14A
7iwcifr
9 Oct 20
Proxy related to merger
4:44pm
10-K
3qrj9w1tek9kge9cy3l9
28 Mar 19
Annual report
7:31am
- Prev
- 1
- Next